中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Main points and inspirations of guidance for bioequivalence studies of oral solid products in European and American countries

文献类型:期刊论文

作者Zhang Yifan; Zhong Dafang
刊名Chinese Journal New Drugs
出版日期2014
卷号23期号:13页码:1501-1505
关键词solid oral product bioequivalence study guidance reference product highly variable drug products
ISSN号1003-3734
其他题名欧美国家口服固体制剂生物等效性试验指导原则的要点和启示
文献子类Article
英文摘要Bioequivalence study is critical for evaluating the inherent quality of generic oral solid products. Guidelines have been issued by regulation agencies of European and American countries and revised based on applications and experiments. Their main points include the study design, selection of reference product, special requirements for highly variable or narrow therapeutic index drug products, etc., reflecting the latest developments. In the corresponding draft guidance of China Pharmacopoeia, international new criteria are adopted. The agreement evaluation of generic drug products in China will play an important role in promoting the bioequivalence of oral solid products.
WOS研究方向Pharmacology & Pharmacy (provided by Clarivate Analytics)
语种中文
CSCD记录号CSCD:5184571
源URL[http://119.78.100.183/handle/2S10ELR8/269328]  
专题上海药物代谢研究中心
通讯作者Zhang Yifan; Zhong Dafang
作者单位Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
推荐引用方式
GB/T 7714
Zhang Yifan,Zhong Dafang. Main points and inspirations of guidance for bioequivalence studies of oral solid products in European and American countries[J]. Chinese Journal New Drugs,2014,23(13):1501-1505.
APA Zhang Yifan,&Zhong Dafang.(2014).Main points and inspirations of guidance for bioequivalence studies of oral solid products in European and American countries.Chinese Journal New Drugs,23(13),1501-1505.
MLA Zhang Yifan,et al."Main points and inspirations of guidance for bioequivalence studies of oral solid products in European and American countries".Chinese Journal New Drugs 23.13(2014):1501-1505.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。